UBS Group’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,000
Closed -$676K 10601
2025
Q3
$676K Buy
+10,000
New +$725K ﹤0.01% 5871
2024
Q2
Sell
-50,000
Closed -$2.88M 9602
2024
Q1
$2.88M Buy
+50,000
New +$2.58M ﹤0.01% 3569
2021
Q2
Sell
-11,600
Closed -$541K 9434
2021
Q1
$541K Buy
+11,600
New +$513K ﹤0.01% 4802
2020
Q4
Sell
-686
Closed -$20K 8437
2020
Q3
$20K Buy
+686
New +$19.3K ﹤0.01% 6299
2020
Q1
Sell
-1,678,000
Closed -$49.6M 8019
2019
Q4
$49.6M Buy
1,678,000
+1,613,600
+2,506% +$42.7M 0.02% 780
2019
Q3
$1.8M Buy
+64,400
New +$1.86M ﹤0.01% 3396

Other funds holding CTVA

UBS Group's CTVA Position: Q1 2026 in Review

UBS Group increased its Corteva (CTVA) stake by 43% in Q1 2026, buying an estimated $65.8M and bringing the position to 2,898,418 shares worth $243M. The position accounts for 0.04% of the portfolio, ranked #528.

UBS Group first reported a position in CTVA in Q2 2019 and has held it in 28 quarters since. 1,478 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • UBS Group held 2,898,418 shares of Corteva worth $243M as of Q1 2026.
  • UBS Group bought 873,278 Corteva shares in Q1 2026, an estimated $65.8M.
  • Corteva made up 0.04% of UBS Group's portfolio in Q1 2026, its #528 holding.
  • UBS Group first reported a position in Corteva in Q2 2019 and has held it in 28 quarters since.
  • 1,478 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.